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ABSTRACT 
 
Anna Van Meter: Validating Cyclothymic Disorder in a Youth Sample 
(Under the direction of Andrea Hussong, PhD, Eric Youngstrom, PhD,  
Jennifer Kogos Youngstrom, PhD) 
 
Four subtypes of pediatric bipolar disorder (PBD) – bipolar I, bipolar II, cyclothymia and 
bipolar not otherwise specified (NOS) – are defined in DSM-IV-TR. However, these 
definitions are not followed consistently by research investigators or clinicians, resulting 
in a lack of agreement and understanding regarding the diagnosis of PBD. The present 
study uses the diagnostic validation method first proposed by Robins and Guze (1970), to 
systematically evaluate cyclothymic disorder as a distinct diagnostic subtype of bipolar 
disorder (BP). Using a clinical sample (N= 827), participants with cyclothymic disorder 
(N=52) were compared to participants with other BP disorders and to participants with 
non-affective disorders. Results indicate that cyclothymic disorder shares many 
characteristics with other bipolar subtypes, supporting its inclusion on the spectrum. 
Additionally, cyclothymia could be reliably differentiated from non-bipolar disorders 
based on irritability, sleep disturbance, age of symptom onset, comorbid diagnoses, and 
family history. These results highlight areas for future research. 
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Validating Cyclothymia in a Youth Sample 
Statement of Importance 
Pediatric bipolar disorder (PBD), as a distinct diagnosis, is a relatively new concept 
within psychology. Only in the past 15 years or so has the field begun to actively recognize and 
diagnose the episodes of manic and depressive symptoms that characterize bipolar disorder in 
young people (B Geller & Luby, 1997). The past decade of research has yielded significant gains 
in better understanding the disorder (E. Youngstrom, Birmaher, & Findling, 2008). However, 
controversy and debate have led research groups in different directions, possibly limiting the 
progress in accurately defining and describing bipolar disorder and its subtypes in young people 
(Kessler, Avenevoli, & Merikangas, 2001). 
The greatest source of diagnostic debate is in regard to the subthreshold forms of the 
disorder. Although there is some disagreement regarding the phenotypes for bipolar I and II, the 
definition of bipolar disorder not otherwise specified (BP NOS) and cyclothymic disorder are 
subject to greater controversy and less understanding. In fact, while there are distinct DSM 
criteria for each, it has been noted in the literature that many research groups do not attempt to 
differentiate subthreshold subtypes, relying instead on a loosely defined NOS grouping (Kessler, 
et al., 2001; E. Youngstrom, et al., 2008). Failing to differentiate between diagnostic subtypes 
limits the knowledge that can be gained. Subthreshold cases may, in fact, be in greatest need of 
investigation. These presentations are more common than BP I and II in young people 
(Lewinsohn, Klein, & Seeley, 1995) and prove to be just as impairing as the syndromal subtypes 
in both clinical and community studies (Axelson, et al., 2006; Birmaher, Axelson, Goldstein, et 
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al., 2009; Birmaher, et al., 2006; Findling, et al., 2005; Judd & Akiskal, 2003; Kessler, et 
al., 2001). Furthermore, subthreshold bipolar disorder likely offers the best opportunity for 
preventative intervention (Berk, et al., 2007; Chang, 2008; Klein, Depue, & Slater, 1986; 
Miklowitz & Chang, 2008).  
The differentiation of subthreshold bipolar disorder into the subtypes of cyclothymia and 
BP NOS is important in order to elucidate the risk factors, developmental course, and potential 
for preventative measures that apply to each.  
Background and Significance 
Within the bipolar disorder category, symptom presentations meeting some, but not all, 
of the criteria for bipolar disorder I or II are common, but not well defined (Akiskal, et al., 2000). 
Depending on the research group and the specific phenomenology, these presentations are 
typically labeled as BP NOS and cyclothymia. Subsyndromal bipolar disorder has been found in 
6-13% of the general adolescent population, while BP I and II are present in 0.5-3% (Chang, 
Steiner, Dienes, Adleman, & Ketter, 2003; Kessler, et al., 2009; Lewinsohn, et al., 1995). In spite 
of the higher rates of subsyndromal cases, most research groups combine all subthreshold 
presentations into a broad BP NOS group. This is due, in part, to the fact that the DSM 
inclusion/exclusion criteria for bipolar disorder subtypes are not particularly well-defined and do 
not fully encompass the range of symptoms commonly observed (E Youngstrom, 2009), some 
aspects are arbitrary (hypomania = 4+ days), and there is a belief that if the criteria were revised 
to better reflect patients’ symptoms, the composition of diagnostic groups would be different 
(Vieta & Phillips, 2007). Discontent with DSM criteria, particularly in regard to subthreshold 
cases, (Schotte & Cooper, 1999) has led to the advent of study-specific research diagnostic 
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criteria and the unintended consequence of impeding comparison of results across groups (Duax, 
Youngstrom, Calabrese, & Findling, 2007). 
For example, in a large, longitudinal study of bipolar youth, the criteria for BP NOS have 
been revised to include (a) episodes of hypomania in the absence of any depressive episode, (b) 
episodes of mania that do not meet duration criteria, or (c) episodes of an insufficient number of 
manic symptoms that do meet duration criteria (Axelson, et al., 2006). The inclusion of these 
cases in research is important; however, placing them under the umbrella of the NOS diagnosis is 
problematic. Those with hypomania alone could also be categorized as cyclothymic, given 
sufficient duration, or given the difficulty differentiating hypomania from normal childhood 
behavior, might not be considered ill at all. In other studies, the NOS grouping may also include 
those who exhibit irritability while [hypo]manic, but whose mood is not elated or elevated 
(Leibenluft, Charney, Towbin, Bhangoo, & Pine, 2003). These inconsistencies in diagnostic 
grouping are further perpetuated by the use of different diagnostic techniques. Although the use 
of a semi-structured interview, such as the K-SADS, is the “gold” standard for diagnosis, it is not 
used by all research groups. Different methodologies, particularly those that do not inquire 
directly about important aspects of bipolar disorder (e.g. episodicity, or “cardinal” symptoms, 
such as decreased need for sleep or grandiosity), are likely to yield unreliable diagnoses (Mick, 
Biederman, Pandina, & Faraone, 2003; E Youngstrom, Meyers, et al., 2005). So, although data 
exist on children with BP NOS, the heterogeneity of the sample is so great that generalizations 
cannot be made.    
For the most part, cyclothymia is not described in research or diagnosed clinically (E 
Youngstrom, Youngstrom, & Starr, 2005). It was not included in the “Diagnostic guidelines for 
bipolar disorder: A summary of the International Society for Bipolar Disorders Diagnostic 
4 
 
Guidelines Task Force Report” (Ghaemi, et al., 2008). Those studies that do include it, are often 
based on clinical diagnoses. As a result, little is known about cyclothymia in young people. 
Furthermore, given the fact that evidence indicates that cyclothymia may be one of the more 
prevalent subtypes of bipolar disorder in adults (Akiskal, Lancrenon, & Hantouche, 2006; 
Hantouche, 2009), the absence of this group in youth research suggests that the other diagnostic 
subtypes – particularly BP II and NOS – are likely contaminated with youth meeting criteria for 
cyclothymia. If cases of cyclothymic disorder exist, but are not being diagnosed, then they are 
either being (1) misdiagnosed as another mood disorder, (2) misdiagnosed as a non-affective 
disorder, or (3) not coming to clinical attention. The diagnosis of cyclothymia can be made 
reliably in research (Depue, 1981; Mazure & Gershon, 1979), but for some reason, it has been 
largely ignored in pediatric studies, resulting in a potentially inaccurate picture of pediatric 
bipolar disorder overall. 
Why do we care about categories? There is a movement now within psychology – and 
developmental psychopathology specifically – to move to a dimensional, rather than categorical 
system of classification (Kraemer, 2007). If a dimensional scale were adopted for pediatric 
bipolar disorder, it would eliminate the need to discuss the fine demarcations of different 
subtypes, and the pros and cons of combining some or all bipolar disorders under the same 
category would not matter. However, research suggests that different presentations of bipolar 
disorder are heterogeneous in their etiology and course (E Youngstrom, 2010) and, without 
describing these differences, the ability to forecast prognosis with any precision, or to create 
targeted treatments might be limited. Furthermore, diagnostic systems based on theory, rather 
than clinical presentation may be more technically valid, but tend to be inflexible and under-
utilized (Brieger & Marneros, 1997).  
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The scope of this paper does not allow for a full discussion of the benefits and limitations 
of a categorical versus dimensional approach to diagnosis. Although the symptoms/presentation 
of bipolar disorder may, in fact, be dimensional, the system within which mental health services 
are currently administered requires categorical definitions (Ruscio & Ruscio, 2002; Widiger & 
Clark, 2000). Therefore, the prudent thing to do is to make the system work as well as possible, 
by utilizing a comprehensive set of subtypes that allow for the most appropriate diagnosis and 
treatment. A more well-defined set of diagnostic categories seems to be indicated for pediatric 
bipolar disorder in particular (Kessler, et al., 2001). There is a wide range of symptomatology 
that gets labeled with the bipolar banner. Because we do not yet know the developmental course 
of different symptom presentations or the best way to treat them, it is important to study them 
with as much detail as possible. Within research, using broad categories has been shown to 
weaken diagnostic precision, inhibit the development of diagnostic tools, undermine prognostic 
accuracy, confuse efforts to understand the biological and genetic underpinnings of a disorder 
and lead to ineffective treatments (Baldessarini, 2000). Distinct diagnoses are necessary to make 
progress toward fully understanding a disorder. 
In addition to the intellectual merit of finely-demarcated diagnoses, there are compelling 
clinical considerations in favor of accurately diagnosing subthreshold cases (Brieger & 
Marneros, 1997). Previous mood disorder research has shown that failure to recognize 
subthreshold cases may leave up to one-third of treatable cases under-served (Angst, 
Merikangas, & Preisig, 1997). This is a real concern considering that early onset bipolar disorder 
may represent a more pernicious type than adult onset, and treatment could stave off some 
consequences associated with the disorder (Berk, et al., 2007; Perlis, et al., 2004). Those patients 
who present with clear mania and/or depression are easier to make treatment decisions about, 
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insofar as it is clear that they need treatment. Fuzzier cases, on the other hand, introduce more 
room for interpretation and uncertainty about whether to treat and how to treat (Kowatch, 
Fristad, et al., 2005). Clear classifications should facilitate the accurate diagnosis and treatment 
of subthreshold cases and may offer an opportunity for preventive intervention and improved 
prognosis over time (Schotte & Cooper, 1999; Vázquez & Tondo, 2007).  
Why do we care about cyclothymic disorder? There are two DSM diagnoses that 
currently qualify as subthreshold bipolar disorder, cyclothymia and BP NOS. Cyclothymia is the 
forgotten class of bipolar disorder, at risk for extinction, as it has gotten largely absorbed into the 
NOS category, and / or confounded with cyclothymic temperament, within both clinical and 
research settings (Brieger & Marneros, 1997; E Youngstrom, 2009). However, there is ample 
evidence that cyclothymia deserves to be maintained as a distinct diagnostic category.  
 Cyclothymia was first described by Ewald Hecker, in 1898, in much the same way that 
the disorder is now characterized in the DSM – brief depressions followed by brief manias 
(Koukopoulos, 2003). Later, Kraepelin further described cyclothymia on the spectrum of bipolar 
disorders as a mild form or predisposition to the more severe subtypes (Akiskal, 2001; Trede, et 
al., 2005). Remarkably, a large portion of these early descriptions remains relevant today and, 
although history cannot be equated with truth, the persistence of cyclothymic features as a 
known clinical presentation justifies the further exploration of its validity as a diagnosis in 
children (Brieger & Marneros, 1997).  
 One of the challenges of maintaining cyclothymic disorder as a clinical diagnosis is the 
fact that, due to the less-intense depressed and manic episodes, many people with cyclothymia do 
not seek / receive treatment. When people with cyclothymic disorder do seek treatment, it is 
most often during a depressive episode, as hypomania can be a relatively pleasant state for the 
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person experiencing it (Akiskal, Djenderedjian, Rosenthal, & Khani, 1977). If the chief 
complaint is depression, people with cyclothymia may be misdiagnosed with dysthymic disorder 
or unipolar depression unless they are carefully questioned about past symptoms of hypomania. 
Similarly, if the patient and parent are not asked about episodic mood, the externalizing 
behaviors associated with hypomania may be the primary focus, leading to diagnoses of 
oppositional defiant disorder or conduct disorder (Fields & Fristad, 2009; E Youngstrom, 2009). 
This problem is particularly salient in youth populations, as hypomania can be hard to 
distinguish from normal childhood activity (E. Youngstrom, et al., 2008) and, in general, the 
reliability of mania diagnoses is low (Kessler, Rubinow, Holmes, Abelson, & Zhao, 1997). In 
addition, though scales exist to measure mania, none have been standardized on a large 
community sample (E Youngstrom, 2010). This is a particular limitation when considering 
subthreshold presentations of mania, as tools standardized only on clinical samples may not be 
sensitive enough to pick up on hypomania. As a result, hypomania may go undiagnosed, even 
when an assessment of manic symptoms is made. 
In spite of the low rates of diagnosis and poor representation in research, cyclothymia 
may be the most common form of bipolar disorder (Hantouche, 2009; Lewinsohn, Klein, & 
Seeley, 2000). This is especially true in youth (Duax, et al., 2007), as cyclothymia may be a 
prodrome to BP I and II (Lewinsohn, et al., 2000). Due to the subthreshold symptomatology and 
tendency toward diagnostic escalation (Shankman, et al., 2009), those meeting criteria for 
cyclothymia in their youth may provide the best example of the course of bipolar disorder; 
including factors that act in protective or risk-generating capacities (Akiskal, et al., 1985). 
Additionally, the protracted course of cyclothymia may be an important outcome determinant. 
Previous research has shown that a more chronic symptom presentation often indicates a 
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treatment-refractory form of the disorder (Birmaher, Axelson, Goldstein, et al., 2009; Birmaher, 
et al., 2006) associated with greater comorbidity (McElroy, Strakowski, West, Keck, & 
McConville, 1997; Schraufnagel, Brumback, Harper, & Weinberg, 2001). The evidence suggests 
that, although the specific depressive and hypomanic symptoms may be less severe in 
cyclothymia than in other forms of bipolar disorder, the duration of these symptoms is an 
important clinical consideration. Similarly, a proposal for the classification of depression in 
DSM-V advocates the use of a two-axis system – severity and chronicity – it may be that bipolar 
disorders could also be classified using this system (Klein, 2008). Regardless, it is important to 
account for the chronic nature of cyclothymia in research, and to investigate the other factors 
associated with this presentation.Without the kind of definitive diagnostic data provided by 
genetic or biological tests, the study of pediatric bipolar disorder can only benefit from research 
that includes cyclothymia. Similarly, within clinical settings, having options that describe 
symptomatology more precisely should aid clinicians in making more accurate diagnostic and 
treatment decisions (Schotte & Cooper, 1999). With the hope of providing added diagnostic 
utility to both academic and clinical settings, the goal of this study is to validate the diagnosis of 
cyclothymia in young people. 
Validation approach. There is no one accepted practice by which psychiatric diagnoses 
are validated. In fact, many childhood disorders have not been validated, beyond 
phenomenology, which is a major limitation, especially for research (Cantwell, 1996). This issue 
came to the forefront a decade ago, in Cantwell’s 1996 paper Classification of Child and 
Adolescent Psychopathology, but the challenges posed then remain today:  
1. Is a categorical or dimensional approach more appropriate? 
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2. Can the disorder be conceptualized as quantitatively or qualitatively different 
from normal? 
3. Can categories described in DSM be considered to be discrete entities? 
4. How is comorbidity handled? 
5. How are subthreshold conditions considered? 
The issue of validation may be of particular interest now, as DSM V and WHO/ICD-11 
committees are meeting to determine the future classification system. In the absence of a 
laboratory test, diagnostic validation is complicated. The questions posed above are not easily 
answered, particularly within young populations where developmental considerations cloud the 
picture. Still, it is important to approach validation systematically and to use methods that allow 
for consistency in both academic and clinical settings (Cantwell, 1996). 
There are a number of competing validation approaches; for the purposes of this paper, 
two primary models were considered. First, the psychological approach, which is often described 
as the “nomological net,” and, second, the system first proposed by Robins and Guze (1970) and 
used widely (with modifications) in psychiatry. 
The nomological net approach is based on the idea that many concepts in psychology, 
including diagnoses, do not have clear boundaries that can be directly measured (Ruscio & 
Ruscio, 2004). It may be impossible to measure exactly where a given factor begins and ends. 
So, rather than relying on an arbitrary measurement system, a nomological net for the construct 
of interest can be created from related factors that are measurable (Cronbach & Meehl, 1955). 
For example, we cannot directly measure a person’s personality: there is no blood test or brain 
scan that will reveal what an individual is like. However, we can measure behaviors that are 
influenced by personality and, in doing so, create a picture of an individual’s personality that can 
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be compared to others’. This approach is relatively flexible; scales can be constructed to include 
a wide range of possible presentations and do a nice job of describing a latent factor.  
The nomological net approach holds some advantages for the consideration of bipolar 
spectrum disorders. Evidence increasingly suggests that these disorders are the result of 
numerous risk factors and that the disease characteristics (age of onset, length and frequency of 
episodes, severity, etc.) vary widely between individuals (Birmaher, Axelson, Goldstein, et al., 
2009). The use of a nomological net would allow for the description of these and other constructs 
related to the disease on an individual basis. Historically, there has been some tension between a 
“one size fits all” model of diagnosis and a polythetic approach, allowing for greater 
individuality in diagnostic decisions (Tucker, 1998). Greater detail regarding symptomatology 
and diagnostic description holds advantages for research; the more clearly we can define 
constructs of interest, the better we may be able to understand the underlying factors. However, 
though there is a certain intellectual appeal in this approach, clinically, a multi-dimensional 
approach may not be the most logical (Ruscio & Ruscio, 2004; Widiger & Clark, 2000).  
The Robins and Guze approach has been used widely in diagnostic validation studies, and 
its publication marked a shift in the basis of the DSM from a primarily clinical judgment-based 
system to one based on an evidence-based model (Andreasen, 1995; Feighner, et al., 1972). In its 
original form, it provides a framework of five categories (described as “phases”) of evidence 
collection that contribute to the validation of a diagnostic classification – Clinical Description, 
Laboratory Studies, Delimitation from Other Disorders, Follow-Up Studies, and Family Studies. 
The categories lend focus to the consideration of new psychiatric diagnoses and may help 
clinical researchers to identify areas in the literature that need further development in order to 
better understand or describe a diagnosis. It is a practical structure that promotes a rigorous 
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system for the categorization of disorders without being prohibitively rigid (Widiger & Trull, 
1991). For most psychiatric disorders, the field is just beginning to understand the biological and 
genetic underpinnings. The Robins and Guze approach makes room for discoveries from the lab 
without discounting the importance of clinical judgment. 
For the purpose of validating cyclothymic disorder in youth, and reconciling clinical 
utility with academic merit, the Robins and Guze approach may be a more appropriate starting 
point. Although cyclothymia is an intermediate diagnosis on the bipolar spectrum, for which an 
argument in favor of a dimensional approach could be made, within a clinical setting, a truly 
dimensional framework is impractical. Although each case of bipolar disorder may be slightly 
(or even drastically) different, the way in which they are treated is not; in practice, psychiatry 
and psychology rely on classification to delineate the healthy from the sick and make treatment 
decisions accordingly (Widiger & Trull, 1991). As such, the use of a system that is integrated 
with the DSM is indicated. In previous studies, cyclothymia in adults has been successfully 
validated using modified versions of the Robins and Guze phases, (1) family history, (2) follow-
up studies, (3) delimitation from other disorders, (4) psychopharmacologic-induced hypomania, 
(5) lithium response (Akiskal, et al., 1977; Klein, et al., 1986). Additionally, the Robins and 
Guze phases have been used to validate pediatric bipolar disorder, demonstrating the fit of this 
framework to this class of disorders (Biederman, et al., 2003; Findling, et al., 2001; B Geller & 
Tillman, 2005). In the interest of consistency and generalizability, using the same framework for 
validation has advantages (Birmaher, et al., 2006).  
A more theory-driven approach, like the nomological net, should not be rejected, it is 
important to pursue an understanding of this disorder beyond symptomatology. The Robins and 
Guze method is a nice compromise between a theoretical and clinical approach; it combines 
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clinical observation with more theory-driven research. Importantly, the Robins and Guze method 
can provide a clear picture of what is missing from the research, in a way that a less-defined 
framework cannot.  
For the purpose of validating cyclothymia in youth, the existing data will be organized 
into three of Robins and Guze’s five categories, Clinical Description, Delimitation from Other 
Disorders, and Family Study, demonstrating the evidence in support of it as a diagnostic category 
and highlight the areas in which further research is warranted.  
 Clinical description. A review of the pediatric bipolar disorder literature and previous 
studies of cyclothymia in adults led to the identification of seven constructs to explore as 
potential discriminating clinical features of pediatric cyclothymia. Of the five categories of 
validation, clinical description may be the most important diagnostically, as clinicians are likely 
to focus on presenting symptoms, over some of the other categories – laboratory studies, family 
studies, and follow-up studies – that serve more of a research purpose. 
Depression and hypomania. Cyclothymia is defined by a clinical course alternating 
between periods of depressive and hypomanic symptoms for at least one year in youths or two 
years in adults, during which time the individual is not symptom-free for more than two months 
(American Psychiatric Association, 2001). Any symptom presentation meeting full criteria for 
mania and/or depression would result in a diagnosis of bipolar I or II. As mentioned previously, 
one of the debates about pediatric bipolar disorder has been the criteria applied to episodes of 
mania and hypomania, specifically, whether or not the same criteria should be used for children 
and adults (Fields & Fristad, 2009; E. Youngstrom, et al., 2008). Although research has shown 
that pediatric bipolar disorder, including cyclothymia, can be diagnosed using adult criteria, 
many research groups choose to use less stringent criteria for both duration and intensity of 
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manic symptoms (Faedda, Baldessarini, Glovinsky, & Austin, 2004; B Geller & Luby, 1997; E. 
Youngstrom, et al., 2008). As a result, it may be that cyclothymia is often misdiagnosed as 
another subtype of bipolar disorder, when subthreshold symptoms are treated as meeting full 
criteria.  
 For this study, the Longitudinal Evaluation of All Available Data (LEAD) standard of 
diagnosis was used to designate the youth with cyclothymic disorder, in addition to all other 
diagnostic categories (Spitzer, 1983). The LEAD standard was developed in the absence of a 
laboratory test for the accurate diagnosis of mental illness, it takes into account longitudinal 
information in order to assess the disorder over time, it is executed by experts who have 
demonstrated proficiency in the diagnosis of the disorder in question and agree by consensus on 
the appropriate diagnosis, and it relies not only on information provided by the subject, but also 
collects information from family members, previous healthcare providers and others as 
appropriate. The inclusion of information beyond that provided in the K-SADS interview may 
improve the validity of the diagnosis, as research shows that the use of standardized diagnostic 
interviews alone can result in misdiagnosis (Rettew, Lynch, Achenbach, Dumenci, & Ivanova, 
2009) In this study, the LEAD diagnoses take into account the information collected through the 
K-SADS interview, study questionnaires, family history and clinical judgment. Youth with 
cyclothymia will be expected to suffer impairing symptoms, of both depression and mania, that 
fail to meet full criteria for either number of symptoms or duration. 
 Irritability. Cyclothymic temperament is one possible explanation for the elevated levels 
of irritability seen among people with cyclothymia. Regardless of its origin, the irritability seen 
among people with cyclothymia during both hypomanic and depressive periods is a marker of 
the disorder. Unfortunately, irritability is also a symptom of many other childhood disorders, 
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resulting in the frequent misdiagnosis of conduct disorder and oppositional defiant disorder 
(Biederman, et al., 2000; E. Youngstrom, et al., 2008). This is further complicated by the very 
high rates of comorbidity found in pediatric bipolar disorder (Faedda, et al., 2004; Wozniak, 
Biederman, Kiely, et al., 1995). In the case of cyclothymia, the irritability should coincide with 
episodes of hypomanic and depressive symptoms, not occur all the time, as it might in ADHD or 
other comorbid disorders. Concentrating on the episodic nature of the disorder is the best way to 
ensure that a symptom is due to the bipolar disorder (E. Youngstrom, et al., 2008). The 
irritability experienced during depressive and hypomanic episodes may be qualitatively different. 
People with cyclothymic disorder tend to be impulsive and unpredictable during hypomanic or 
mixed states with irritable mood directed at others, whereas during depressive periods, they may 
be touchy and sensitive, but also tend to have self-directed irritability consistent with guilt, 
rumination, and low self-esteem (Akiskal, et al., 1977; Akiskal, et al., 1985). 
Irritability is a complicated symptom to assess in pediatric bipolar disorder. It is included 
among the DSM criteria for mania, and considered by many to be a hallmark symptom of 
pediatric mania, but it may also be present during depressive phases (Birmaher, Axelson, 
Strober, et al., 2009; Kowatch, Youngstrom, Danielyan, & Findling, 2005). Experts in pediatric 
bipolar disorder confirmed that over 90% of youth with bipolar diagnoses show moderate or 
severe irritability during periods of elevated mood. This type of irritability is often associated 
with aggression and outward hostility (Jensen, et al., 2007). Irritability experienced during 
depression may be qualitatively different from the variety found during periods of elevated 
mood. Therefore, in order to address the hypothesis that people with cyclothymia will exhibit 
trait-like irritability, occurring in both hypomanic and depressive episodes, two constructs of 
irritability will be assessed.  
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 Comorbidity. The presence of other psychiatric disorders is common in youth with 
bipolar disorder, often making diagnosis difficult and complicating treatment (Lewinsohn, et al., 
1995; Spencer, et al., 2001; Wozniak, Biederman, Kiely, et al., 1995). Two of the most common 
comorbid diagnoses are ADHD and anxiety disorders (Kowatch, Youngstrom, et al., 2005). Due 
to significant symptom similarities, bipolar spectrum disorders are also often misdiagnosed as 
one of these disorders (Akiskal, et al., 1985; Faraone, Biederman, Wozniak, & Mundy, 1997; 
Reich, Neuman, Volk, Joyner, & Todd, 2005; Singh, DelBello, Kowatch, & Strakowski, 2006).  
 Given the symptoms of cyclothymia, particularly restlessness, irritability and impulsivity, 
is often misdiagnosed as ADHD, and it may be several years before a proper diagnosis is made 
(Faedda, et al., 2004). Some experts hypothesize that a prolonged period to diagnosis may result 
in greater burden of illness, including more comorbid diagnoses (McElroy, et al., 1997; 
Schraufnagel, et al., 2001). Given the average length of duration until diagnosis, a higher number 
of comorbid diagnoses may be present among people with cyclothymia. Additionally, people 
with cyclothymia tend to have a variety of psychiatric disorder present in their family history, 
which may lead to more comorbidity (Akiskal, Hantouche, & Allilaire, 2003; Findling, et al., 
2005).  
 Two types of comorbid diagnoses are of particular conceptual interest: ADHD and 
anxiety disorders. The impulsive and restless nature of people with cyclothymic disorder, along 
with the chronicity of symptoms, make ADHD and cyclothymia hard to differentiate 
(Schraufnagel, et al., 2001) and the two often co-occur (Holtmann, et al., 2009). Due to their 
temperamental nature, and proclivity to overreact in situations perceived as stressful, people with 
cyclothymia may also be more inclined toward anxiety disorders (notably panic and separation 
anxiety) (Akiskal, et al., 1985; Perugi, 2002; Wagner, 2006).  
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 Age of Onset. The age of symptom onset in bipolar disorder has important implications 
for prognosis (Craney & Geller, 2003). Generally, the earlier symptoms begin, the more severe 
the disease will ultimately become (Perlis, et al., 2004). Considering that (1) cyclothymia 
appears to have a temperament foundation, (2) that cyclothymia can be the prodrome to other 
forms of bipolar disorder (Akiskal, et al., 1985), and (3) that studies show subsyndromal bipolar 
may have a younger mean age of symptom onset than BP I and II (Lewinsohn, et al., 2000), it is 
likely that cyclothymia has an earlier age of onset than other forms of bipolar disorder 
(Dickstein, et al., 2005). The other aspect of onset that may be important is whether a person’s 
first episode is elevated or depressed. Evidence indicates that in early onset bipolar disorder, the 
first episode is usually depressed. This is important because people with a depressed index 
episode may remain symptomatic much longer than those who present with [hypo]mania 
(Strober, et al., 1995). Because cyclothymia has such a protracted course, the initial episode is 
more likely to be depressed. 
 Sleep disturbance. A reliable way to identify youth with bipolar disorder is by 
identifying changes in sleep patterns / sleep disturbance coinciding with mood episodes (B 
Geller, et al., 2002; Harvey, Mullin, & Hinshaw, 2006). Although people with cyclothymic 
disorder do not experience full-blown mania, and may not demonstrate decreased need for sleep, 
they often experience significant sleep disturbance, due to the restlessness and agitation 
associated with their disorder (Findling, et al., 2005; Kowatch, Youngstrom, et al., 2005) This 
disturbance may occur during both hypomanic and depressive episodes. 
 Delimitation from Other Disorders. Being able to differentiate cyclothymia from 
other forms of bipolar disorder is perhaps the most important – and challenging – aspect of the 
validation of this diagnosis. As mentioned, pediatric bipolar disorder can be difficult to 
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differentiate from disruptive behavior disorders, ADHD and, in some cases, from depression. To 
further delineate cyclothymia, a clinician must focus on very specific aspects of the child’s 
symptom presentation – the difference is in the details.  
 Pediatric bipolar may be distinguished from other childhood disorders as follows: 
 ADHD. ADHD may share many symptoms with PBD including restlessness, 
irritability, distractibility, and hyperactivity (Biederman, et al., 2005; Faraone, et al., 1997). 
However, ADHD is a chronic – not episodic disorder. Assessing for episodicity is one of the 
most reliable ways to distinguish PBD (E. Youngstrom, et al., 2008). Additionally, ADHD does 
not include several hallmark symptoms of mania, including grandiosity, hypersexuality, racing 
thoughts, and decreased need for sleep. Each of these symptoms may be used to help make a 
differential diagnosis between PBD and ADHD (B Geller & Tillman, 2005; B Geller, et al., 
2002). 
 Disruptive Behavior Disorders (Oppositional Defiant Disorder / Conduct 
Disorder).The extreme irritability accompanied by rage / tantrum behaviors in pediatric 
[hypo]mania may be mistaken for ODD or CD. Additionally, poor judgment and impulsivity 
exhibited during [hypo]manic episodes may appear similar to the deviant behavior seen in CD. 
Although the symptoms of these disruptive behavior disorders are similar to some seen during 
manic phases of PBD, the features of elevated mood and decreased need for sleep are absent in 
disruptive behavior disorders. Additionally, during depressed or euthymic periods of bipolar 
disorder, these symptoms will be largely absent. Again, the primary way by which to 
differentiate PBD is a change in symptomatology between episodes. 
 Depression. Assessed during manic phases, bipolar I and bipolar NOS are unlikely to 
be confused with depression, given the severity of the manic symptoms. However, bipolar II and 
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cyclothymia, which never reach full mania, may be mistaken for unipolar depression. 
Hypomania is unlikely to result in treatment seeking behavior, in fact, in many cases, it is a 
pleasant state (Akiskal, et al., 1977). Therefore, bipolar II and cyclothymia are more likely to be 
seen clinically during depressive episodes. Unless the clinician specifically asks about prior 
history of hypomania, the patient may easily be misdiagnosed. In order to ensure accurate 
diagnosis, it is important to ask about previous symptoms of elevated mood. Another 
complication is the fact that many bipolar youth have a depressive episode before ever 
experiencing [hypo]mania. This makes it important to inquire about family history and 
symptoms of atypical depression that may signal a predisposition to bipolar disorder (Birmaher, 
Axelson, Goldstein, et al., 2009; E. Youngstrom, et al., 2008). 
 The delimitation of cyclothymia from other subtypes of bipolar disorder takes careful 
consideration of bipolar symptoms.  
Compared to youth with cyclothymic disorder, other BP subtypes differ on the following: 
Symptom Bipolar I Bipolar II Bipolar NOS 
Mania More severe Equivalent Often more severe 
Depression More severe More Severe Equivalent 
Total episode duration Shorter Shorter Equivalent 
Irritability Less chronic Less severe Less chronic 
Age of Onset Later Later Equivalent 
Index episode Less likely depressed Less likely depressed Less likely depressed 
Sleep disturbance More severe Equivalent More severe 
Family History Less mental illness Less  mental illness Less  mental illness 
(Birmaher, Axelson, Goldstein, et al., 2009; Faedda, et al., 2004; Findling, et al., 2005; Klein, et 
al., 1986; Kowatch, Youngstrom, et al., 2005; Lewinsohn, et al., 1995) 
 
 Family Study. There is significant evidence that bipolar disorder is heritable. Although 
the exact rates vary across studies, generally a child of a bipolar parent will be approximately 5x 
more likely to develop bipolar than a child of healthy parents (Hodgins, Faucher, Zarac, & 
Ellenbogen, 2002; Tsuchiya, Byrne, & Mortensen, 2003). Furthermore, children in families with 
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bipolar disorder tend to have elevated rates of a number of other psychiatric disorders including 
depression, ADHD and anxiety (DelBello & Geller, 2001).  
 In a study of youth with manic symptoms, the proportion of those with cyclothymic 
disorder with a bipolar parent (versus without) was higher than any other diagnostic group, 
including those participants with bipolar I and II (Findling, et al., 2005). Additionally, there is 
evidence that the presence of a family history of mood disorder (both unipolar depression and 
bipolar disorder) is the key factor in differentiating people with cyclothymia from others with 
subthreshold bipolar symptomatology (defined as those with clear cyclothymic symptomatology 
that fails to meet full criteria, particularly episodicity, or as cases with definite dysthymia and / or 
depression, but limited hypomanic features) (Akiskal, et al., 1977; Depue, 1981).  
Family history of psychiatric disorder is a significant factor in one’s risk for bipolar 
disorder (Findling, et al., 2005). However, heritability of psychiatric disorder is relatively non-
specific (DelBello & Geller, 2001); therefore, we will explore family history using three 
constructs (history of bipolar disorder, history of mood disorder, and history of nonspecific 
symptoms), rather than looking at history of bipolar disorder alone.  
Aims  
The primary aim of this study is to explore the validity of cyclothymic disorder as a 
diagnostic subtype of pediatric bipolar disorder and to make a case for its inclusion in future 
studies of bipolar disorder. This aim will be achieved through the testing of 11 hypotheses, 
formulated from the proposed diagnostic validation framework (Robins & Guze, 1970). 
The first phase employs descriptive statistics to show the clinical characteristics of those 
cases diagnosed with cyclothymic disorder. This phase is meant to be exploratory and to help 
with hypothesis generation for future studies of cyclothymic disorder. 
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Clinical description. 
The presence / absence of the following clinical features was evaluated in all youth with 
cyclothymic disorder:  
 Irritability during both elevated and depressive mood states  
 Early age of symptom onset (<10 years) 
 Index episode depressed 
 Multiple comorbid disorders, particularly ADHD and anxiety  
 Poor sleep hygiene 
Hypotheses. 
Delimitation from other disorders. 
Non-bipolar. 
 Youth with cyclothymia will be more irritable than youth with non-bipolar spectrum 
disorders 
 Youth with cyclothymia will have more comorbid disorders than youth with non-bipolar 
spectrum disorders 
 Youth with cyclothymia will experience greater sleep disturbance than youth with non-
bipolar spectrum disorders 
Other bipolar spectrum disorders. 
 Youth with cyclothymia will experience a different pattern of irritability than youth with 
other BP spectrum disorders (elevated irritability during both hypomanic and depressive 
episodes) 
 Youth with cyclothymia will have more comorbid anxiety disorders than youth with other 
bipolar spectrum disorders 
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 Youth with cyclothymia will have an earlier age of symptom onset than youth with other 
bipolar spectrum disorders  
 Youth with cyclothymia will be more likely than youth with other bipolar spectrum 
disorders to experience a depressive episode as their first mood episode 
Family studies. 
 Youth with cyclothymia will have family history of psychiatric disorder, including, but 
not limited to bipolar disorder 
 Youth with cyclothymia will have more total family history of psychiatric disorder than 
youth with other bipolar spectrum disorders 
 Youth with cyclothymia will have more family history of mood disorder than youth with 
non-bipolar spectrum disorders 
Method 
Participants 
Participants were recruited from an urban community mental health center (N =647) and 
from an academic outpatient medical center (N = 180). A sample of patients presenting for 
services at the community mental health clinic were invited to participate in the study. The only 
eligibility requirements were that the patient was between the ages of 5 and 18 and that both the 
patient and their caregiver were able to speak English. The participants from the academic 
outpatient medical center were recruited for a variety of treatment studies for bipolar disorder, 
ADHD, conduct disorder and aggressive behavior. Additionally, children of parents with bipolar 
disorder were recruited to the academic center. The exclusionary criteria at the academic center 
included the same age and language requirements as the outpatient clinic; additionally, 
participants were excluded if they suffered from a pervasive developmental disorder, mental 
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retardation (as determined by educational history, cognitive test scores, or Peabody Picture 
Vocabulary Test - Third Edition), autism (as determined by psychiatric interview or having an 
Autism Screening Questionnaire score of >15).  
The sample is comprised of 496 (60%) male participants and 331 (40%) female 
participants. The sample has an average age of 10.92 years (SD 3.44). Sixty-nine percent (N = 
573) of subjects reported their race as Black, 22% (N= 185) White, 2% (N= 20) Hispanic, .2% 
(N= 2) Asian, and 5% (N= 45) reported race as Other. Two people refused to report race 
information.  
Measures  
A variety of measures will be used to assess the constructs of interest, as follows: 
Construct Measure 
Diagnosis K-SADS and LEAD 
Irritability P-GBI – Select items 
Comorbidity K-SADS and LEAD 
Age of Onset K-SADS 
Sleep disturbance P-GBI – Sleep Subscale (Meyers & Youngstrom, 2008) 
Family History QFMQ 
 
Diagnosis. Diagnosis is the basis on which youth with cyclothymia will be compared to 
the cases with other childhood disorders. Diagnoses were made following the LEAD standard 
(Spitzer, 1983), taking into account the information provided during the semi-structured 
interview using the Schedule for Affective Disorders and Schizophrenia for School-Age 
Children-Present and Lifetime (K-SADS-PL-Plus). All participants and their families from both 
the community mental health center and the academic outpatient medical center completed a 
semi-structured diagnostic interview, the K-SADS-PL (Kaufman, et al., 1997), modified with the 
mood disorders module of the WASH-U-K-SADS (B Geller, Zimmerman, & Williams, 2001). 
The WASH-U-K-SADS inquires about symptoms related to depression and mania that are not 
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well-queried in other diagnostic interviews. The K-SADS was administered to each participant 
and his/her parent by a highly-trained research assistant. In order to achieve interrater reliability, 
research assistants were required to shadow an experienced rater for at least five K-SADS 
interviews and demonstrate item-level kappa>.85. New raters then led five interviews while 
being shadowed by an experienced rater. The kappa score for these five interviews needed to be 
at least .85 for the RA to qualify to lead interviews on his/her own. Following the K-SADS 
interview, all cases were reviewed by a team of expert clinicians (always including a licensed 
clinical psychologist and the K-SADS interviewer). In addition to information from the semi-
structured interview, the case team also reviewed psychiatric records and family history in order 
to reach a consensus diagnosis. In the case of a diagnostic discrepancy, the participant and parent 
would be reinterviewed. Kappa was 0.95 for bipolar diagnoses and 0.91 for all diagnoses when 
comparing consensus to the K-SADS diagnosis (E Youngstrom, Meyers, et al., 2005). In order 
for a participant to receive a diagnosis of cyclothymic disorder, s/he would have to meet criteria 
for hypomanic symptoms and depressive symptoms, along with the duration criteria of being 
symptomatic (to the point of clinical impairment) for at least one year. Additionally, the 
participant’s mood episodes could not meet criteria for mania or for a major depressive episode. 
In the case of a manic, major depressive or mixed episodes occurs within the course of an 
established cyclothymic episode (at least one year in length), the diagnosis for cyclothymia is 
given in addition to a diagnosis of bipolar I (for a manic or mixed episode) or bipolar II (for a 
major depressive episode).  
Irritability. Irritability will be assessed during periods of both depressive and elevated 
mood using select items from the Parent-General Behavior Inventory (P-GBI) (E Youngstrom, 
Findling, Danielson, & Calabrese, 2001). The P-GBI is a modified version of the General 
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Behavior Inventory (GBI) (Depue, 1981), meant to be completed by parents about their child. 
The P-GBI includes questions regarding the child’s depressive, manic, hypomanic and biphasic 
mood symptoms. The questions comprise two scales, the depressive and the hypomanic/ 
biphasic. Both scales have high construct validity and very high internal consistency (alphas of 
0.97 for depression and 0.94 for hypomanic/biphasic) (E Youngstrom, et al., 2001). This scale 
was originally developed in order to be sensitive to subthreshold manifestations of mood 
disorder and has proven to do a good job discriminating cases from the full spectrum of bipolar 
disorders (Depue, 1981; E Youngstrom, et al., 2004; E Youngstrom, Meyers, et al., 2005), 
making it particularly valuable for the current study of cyclothymia. 
Items representing depressive or hypomanic irritability were selected by three 
independent raters. Reliability was high; for depressive irritability, items 3, 14, 34, 39, 44, 50, 
and 53 (Cronbach’s α .87) and for elevated irritability, items 22, 27, 51, and 54 (Cronbach’s α 
.71).  
Comorbidity. The number and type of comorbid disorders for each participant will be 
evaluated according to LEAD diagnoses. The LEAD diagnoses are made by consensus by a team 
of experts, taking into account all axis I diagnoses from the K-SADS interview, prior clinical 
diagnoses, family history and clinical impressions. 
 Age of Onset. As operationalized in other research studies, age of onset refers to the age 
at which a participant first met diagnostic criteria for a depressive, manic, hypomanic , or mixed 
episode (Goldstein, et al., 2005). Given the significant delay that often occurs before an accurate 
bipolar diagnosis is made, in this study, age of symptom onset will be assessed by determining 
the youngest age of symptomatology, rather than diagnosis, as reported in the K-SADS 
interview. The K-SADS inquires about age of onset for each of the disorders covered, including 
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depression and [hypo]mania. The polarity of the index episode (depressive or elevated) will be 
determined by evaluating the younger of the two age of symptom onset variables. 
 Sleep disturbance. Sleep disturbance will be assessed using the seven-item sleep 
subscale from the P-GBI. This scale has shown to have strong reliability in differentiating 
bipolar youth from youth with other psychiatric diagnoses based on reported sleep disturbance 
(Cronbach’s α 0.83) (Meyers & Youngstrom, 2008). 
 Family History. Family psychiatric health history will be reported using The Quick 
Family Mood Questionnaire (QFMQ) (Youngstrom unpublished data). The QFMQ is intended to 
provide a simple method by which information about study participants’ family history of mental 
health issues can be gathered. It consists of an array of questions about mental health history for 
close relatives (parents, grandparents, aunts/uncles, siblings and children), resulting in a total of 
25 checkboxes that respondents can endorse. The QFMQ was validated in a pediatric bipolar 
study of 162 families. The family history information showed a clinically meaningful association 
with youth diagnoses of PBD and the number of family risk factors (a simple sum of the number 
of checks) discriminated cases with diagnoses of PBD from all other cases.  
Procedure 
All involved parents / caregivers signed written consent, youth participants provided 
written assent. The youth and parent each completed the K-SADS interview separately 
(administered by the same interviewer). While the parent was being interviewed, youth, 11 years 
and older, completed a series of questionnaires. While the child was being interviewed, the 
parent/caregiver completed the P-GBI, QFMQ, and other questionnaires. The scores on all 
questionnaires were recused from the consensus diagnosis meeting. The consensus diagnosis 
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meetings followed the Longitudinal Evaluation of All Available Data (LEAD) procedure 
(Spitzer, 1983). 
Direct comparisons of questionnaire scores can be misleading when they are scaled in 
different metrics, or when groups have markedly different variances on instruments that 
otherwise look as if they share the same scale. Without a scale for which differences in 
individual scores can be meaningfully interpreted (as in the case with IQ scores), perceived 
disparities in scores may not represent true differences; one way to lend context to scales without 
meaningful units is to transform scores into a percent of the maximum possible score (POMP). 
Converting summed scores into percents provides a framework by which to interpret differences 
(Cohen, Cohen, Aiken, & West, 1999). For the purposes of this study, scores from the P-GBI and 
family risk factors will be converted into POMP scores. 
A range of analyses will be conducted, as appropriate to each construct of interest. For 
each analysis, except where indicated, the youth with cyclothymia in the sample will be 
compared with every other BP subtype (BP I, BP II, and BP NOS) separately as well as with the 
other participants in the study without bipolar disorder. The participants without bipolar disorder 
will be grouped in four categories – disruptive behavior disorders (DBD), ADHD, depression, 
and depression plus ADHD. Because cyclothymia is most likely to be seen clinically during 
depressive phases and shares many characteristics with ADHD, the decision was made to parse 
out those participants with comorbid depression and ADHD in order to see if the co-occurrence 
of these two disorders results in greater similarity to cyclothymia than depression or ADHD 
alone. 
Where appropriate, age, gender, substance use and Child’s Global Assessment Scale (C-
GAS) (Shaffer, et al., 1983) score will be added to the analyses as covariates. Although previous 
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research has not found sex differences in the prevalence of bipolar disorder (Merikangas, et al., 
2007), it may be that there are differences in youth clinical diagnosis, with boys more likely to 
receive a diagnosis of bipolar than girls (Moreno, et al., 2007). In the study sample, there is no 
difference in gender between those youth with bipolar spectrum disorders and those with non-
affective disorders (X
2
(1)=2.2, p=.13). Some effect from age may be expected, as the sample 
spans a wide age range (5-18) and bipolar disorder is thought to increase in prevalence with age, 
particularly from childhood to adolescence (Lewinsohn, et al., 2000; Perlis, et al., 2004). The 
average age of youth with bipolar spectrum disorders is equivalent to the average age of the 
youth with non-affective disorders (F(1)=1.0, p=.31). Substance use is often associated with 
other psychiatric disorders, including pediatric bipolar disorder (Brook, Cohen, & Brook, 1998; 
Kandel, et al., 1997; Wilens, et al., 1999). In order to control for increased risk due to concurrent 
substance use, a dichotomous variable was created to indicate whether the child and/or his/her 
caregiver endorsed any substance use (by the child). Although this is, admittedly, a liberal 
definition of substance use, given the age of the sample, it seemed prudent to be over-inclusive. 
Sixteen percent of the sample met criteria for any substance use, there was no difference between 
those participants on the bipolar spectrum and the rest of the sample (X
2
(1)=2.6, p=.12) Finally, 
C-GAS scores were used to gauge the child’s current level of overall functioning. Participants’ 
C-GAS scores were used to control for degree of impairment, which may account for greater 
variability in symptom severity than diagnosis. There was a significant difference in mean C-
GAS score between participants with bipolar spectrum disorders (49.1) and those with non-
affective disorders (53.1), F(1)=52.6, p<.0001.  
As indicated, by the results of preliminary analyses, post-hoc analyses will be conducted 
using Tukey’s HSD procedure, unless otherwise noted. Tukey’s HSD allows for between-group 
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comparisons following an ANOVA, correcting for the increased likelihood of Type I error due to 
multiple comparisons. 
Results 
Irritability 
The mean POMP elevated irritability score for youth with cyclothymia was 33.01 (SD 
21), diagnostic sensitivity analyses demonstrate that this is significantly higher than the mean 
score for the rest of the sample (t(808)=-3.21, p <.001). The mean POMP depressive irritability 
score for youth with cyclothymia was 43 (SD 19), which is also significantly higher than the 
mean score for the rest of the sample (t(808) =-4.11, p>.0001). In addition, youth with 
cyclothymia exhibit greater irritability during depressive, rather than elevated, episodes (t(51)=-
3.59, p<.001).  
Total POMP irritability scores (depressive and elevated) for youth with cyclothymia were 
compared to other youth in the sample without bipolar spectrum disorders using one-way 
ANOVA. Results indicate significant variability in irritability across the sample (F(4)=18.32, 
p<.0001). See Table 1. Specific comparisons were as follows: youth with cyclothymia were more 
irritable overall than those youth with a primary diagnosis of ADHD (p<.0001) and those with a 
disruptive behavior disorder (p<.0001). There was not a significant difference between youth 
with cyclothymia and youth with depression (p=.18) or depression plus ADHD (p=.72). Youth 
with cyclothymia and those with depression or depression plus ADHD were also equivalent in 
their ratings of the depressive component of irritability. Youth with cyclothymia did have 
significantly higher elevated irritability scores than the depressed youth (p<.01), but not the 
youth with depression plus ADHD. 
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In a linear regression model, used to control for age, gender, substance use and level 
general functioning (as measured by C-GAS score), diagnosis accounted for a significant portion 
of the variance in irritability. Compared to those youth with cyclothymia, the other disorders 
(with the exception of depression plus ADHD) all resulted in a lower irritability score: DBD 
(B=-25.5 (p<.0001), ADHD (B=-15.9, p<.0001), depression (B=-11.1, p<.005), depression plus 
ADHD (B=-5.3, p=.1) (intercept = 83.2, p<.0001). Child’s gender was also a significant 
predictor, with girls exhibiting greater irritability (B=3.97, p<.05), but age (p=.08) and substance 
use (p=.95) were not. Child’s level of functioning also accounted for a significant portion of 
variance in total irritability score (B=-.95, p<.0001), such that better functioning was associated 
with lower irritability. 
Youth with cyclothymia did not differ from those participants with BP I (p=.26) or BP 
NOS (p=.996) in their level of depressive irritability. Those with BP II had a higher mean level 
of POMP depressive irritability than the youth with cyclothymia (p<.005). Controlling for age, 
gender, substance use and level of functioning did not affect this result. 
Youth with cyclothymia differ only from those with BP I in their mean level of elevated 
irritability (p<.05), such that the mean POMP score for youth with cyclothymia (33.0) is lower 
than the mean POMP score for youth with BP I (47.8). Controlling for level of functioning 
reduced this to a nonsignificant difference; further adjustment for age and gender did not change 
the pattern of findings.  
Repeated-measures ANOVA, investigating the pattern of irritability across elevated and 
depressive periods, was significant (F(3)=4.63, p<.01), such that change in level of irritability 
between elevated and depressed episodes depended on the bipolar subtype. Further consideration 
of the mean difference between elevated and depressive irritability across bipolar subtypes 
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indicated that participants with BP II have a larger difference between levels of irritability than 
each of the other BP subtypes (p<.05). See Figure 1.   
The hypothesis that youth with cyclothymia will have similar levels of irritability in both 
elevated and depressive episodes, was not supported; there was a significant difference between 
episodes, such that greater irritability is experienced during depressive periods (t(51)=-3.59, 
p<.001). 
Comorbidity 
Of the 52 youth with cyclothymia in the sample, 51 (98%) have a comorbid diagnosis. 
Nineteen (37%) have a comorbid anxiety disorder. This is not significantly different from the 
rest of the sample (X
2
 (1)=3.37, p =.07). Forty-three of the youth with cyclothymia (83%) have 
comorbid ADHD; this is significantly different from the rest of sample (X
2
 (1)=9.13, p <.005). 
As a group, the bipolar subtypes do not differ in the number of total comorbid diagnoses 
(F(3)=2.3, p=.08).
1
 See Table 2. No difference was found in the presence of comorbid anxiety 
diagnoses (X
2
(3)=2.9, p=.41). In regard to comorbid ADHD, there was a significant difference 
between subtypes, (X
2
(3)=10.8, p<.05), such that youth with cyclothymia were the most likely to 
meet ADHD criteria.  
Youth with cyclothymia have a higher number of comorbid diagnoses than those youth 
without bipolar spectrum disorders (F(4)=23.8, p<.0001). Using a linear regression model with 
cyclothymia and the non-bipolar spectrum disorders as predictors, and controlling for age, 
gender, substance use and C-GAS score, cyclothymia remains a significant predictor of increased 
comorbidity (p<.0001).  
 
                                                          
1
 Although comorbid diagnoses are a count, rather than a continuous variable, the skew was <3, so ANOVA was 
used to assess differences between groups. Results of a Kruskal-Wallis were equivalent, (X
2
(3)=7.00, p=.07), 
showing no significant difference between subtypes. 
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Age of onset  
Thirty-eight of the youth with cyclothymia (73%) had symptom onset prior to the age of 10. 
This is significantly different from the rest of the sample, X
2
 (1)=14.76, p <.0001. However, 
youth with cyclothymia were not more likely to have mood onset prior to age 10 than the other 
bipolar spectrum disorders, X
2
(3)=6.04, p=.11. Cox regression, designed for analysis of time 
until an event, was used to examine whether or not youth with cyclothymia exhibit mood 
symptomatology at younger ages than children with other bipolar subtypes. Overall, the subtypes 
did not differ in their age of onset, X
2
(3) = 6.7, p=.08. However, there was a significant 
difference between the youth with cyclothymia and the youth with BP II (Wald=5.6, p<.05). See 
Figure 2.  
Forty-three of the youth with cyclothymia (83%) experienced depressive symptoms before 
experiencing hypomanic symptoms. However, there was no difference in the likelihood between 
bipolar subtypes that the index episode would be depressed (p=.91); all bipolar subtypes were 
more likely to report depressive, rather than hypomanic, symptoms first. 
Sleep disturbance 
Youth with cyclothymia had a mean POMP score of 31 (SD 21) on the seven-item P-GBI 
sleep subscale, significantly higher than the rest of the study sample (t(808)= -2.77, p<.01). 
Youth with cyclothymia have a significantly higher mean score on the P-GBI sleep scale 
than those youth with non-bipolar spectrum disorders (p<.01) with the exception of those youth 
with depression and ADHD (p=1.0). This difference holds after controlling for age, gender, 
substance use and C-GAS. When compared to other youth with bipolar spectrum disorders, 
youth with cyclothymia differ only from those with BP II (p<.01), after controlling for age, 
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gender, substance use and C-GAS score. The mean POMP score on the P-GBI sleep subscale for 
youth with cyclothymia (31) was lower than the mean POMP score for those with BP II (53).  
Family history 
All of the youth with cyclothymia in the sample for whom family history was reported 
had family history of psychiatric disorder (n=15). See Table 3. There was no difference in the 
level of bipolar risk between the bipolar subtypes (risk was POMP-scored out of a possible 25 
disorder-family member pairings). Similarly, there was not a significant difference between 
bipolar subtypes in the level of general psychiatric illness risk, though the scores vary 
(Cyclothymia 51, BP 13, BP II 32, BP NOS 32). Unfortunately, these analyses are 
underpowered, family history information was only available for 15 youth with cyclothymia, 
three youth with BP I, six youth with BP II, and 19 youth with BP NOS. 
Youth with cyclothymia have more family risk for psychiatric disorder than those with 
disruptive behavior disorders (p <.05), ADHD (p<.0001), depression (p<.05), but not depression 
plus ADHD (p =.09). Similarly, the youth with cyclothymia have more mood disorder (bipolar or 
depression) risk factors than those with disruptive behavior disorders (p <.05) or ADHD (p<.01). 
Although the results were not significant between youth with cyclothymia and the youth with 
depression (p=.06) or those with depression and ADHD (p=.07), given the low number of 
participants with full family history, and the difference in POMP family mood disorder scores 
(cyclothymic 46, depressed 27, depressed + ADHD 28), differences in the presence of family 
mood disorder in youth with cyclothymia, as compared to those with depression deserves further 
exploration.  
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Discussion 
The primary aim of this study was to validate cyclothymic disorder in a youth population 
using the diagnostic validation system proposed by Robins and Guze (1970). This system makes 
use of five categories of evidence – Clinical Description, Laboratory Studies, Delimitation from 
Other Disorders, Follow-Up Studies, and Family Studies. In this study of 827 youth seen for 
outpatient services, we were able to address three of the five categories. This is the first study of 
cyclothymia in youth and, as such, the analyses may be considered exploratory. Still, careful 
consideration of the data related to Clinical Description, Delimitation from Other Disorders, and 
Family Studies paints a compelling picture – plainly situating cyclothymia on the bipolar 
spectrum and offering clues for future areas of research. 
Irritability. 
Youth with cyclothymia in the sample exhibited the characteristics expected for the most 
part. They showed high levels of irritability associated with both depressive and elevated mood. 
Depressive irritability was more severe, which is interesting, given the fact that people with 
cyclothymia are more likely to be seen for treatment during depressive episodes. It may be that 
the heightened irritability signals increased internal agitation, which is more unpleasant both for 
the individual with cyclothymia and for those close to him/her. Interpersonal difficulties could be 
an important motivator for individuals to seek treatment, considering associated consequences, 
including escalation of mood symptomatology. Additionally, with cyclothymic youth, parents 
might be most likely to take their child for an evaluation when s/he becomes irritable and 
difficult to be around. 
 Irritability was expected to be a distinguishing feature of people with cyclothymia. 
Though a diagnosis of cyclothymia was a significant predictor – more so than any of the other, 
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non-BP disorders – of total irritability (elevated plus depressive), after controlling for age, 
gender, substance use, and C-GAS, the mean irritability score (40.44) for youth with 
cyclothymia was not statistically different from those with depression (32.82) or depression and 
ADHD (36.10). This indicates that the overall irritability score may be driven by the depressive 
irritability score. If that were the case, differences in overall irritability scores between bipolar 
youth and depressed youth might not be expected; depressed youth could have greater depressive 
irritability to balance the elevated [hypo]manic irritability seen in bipolar youth. Further 
exploration suggests that this may, in fact, be the case. Looking at depressive irritability alone, 
youth with cyclothymic disorder have a higher mean score than the youth with DBD or ADHD, 
but not the depressed youth (with or without ADHD). Elevated irritability scores indicate that 
youth with cyclothymic disorder are significantly more irritable than all but the youth with 
depression and ADHD. Conceptually, this makes sense: depressed youth would be expected to 
show depressive irritability, and one of the main features shared by ADHD and [hypo]mania is 
irritability. These results are interesting in that irritability is most often associated with the 
elevated periods of bipolar disorder (Biederman, et al., 2000; Kowatch, Youngstrom, et al., 2005; 
Wozniak, Biederman, Kiely, et al., 1995), but it appears that irritability during depressive 
episodes is, in fact, more severe.  
 The pattern of irritability reported may help to differentiate youth with cyclothymia from 
other bipolar subtypes. However, in this study, the pattern was not as hypothesized; the only 
significant difference was between youth with cyclothymia and those with BP I. Youth with 
cyclothymia were more irritable during depressive than elevated episodes, whereas those with 
BP I exhibited a more consistent level of irritability across episodes. Interestingly, when level of 
functioning was added to the model, the difference was no longer significant. Among the 
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participants with bipolar disorders, level of functioning and irritability were correlated (r=-.2, 
p<.01); opening the possibility that level functioning and irritability are related, independent of 
mood. In fact, the correlation is stronger among those youth with non-affective disorders (r=-.3, 
p<.01). Though it is beyond the scope of this study to determine the direction of this relation, the 
issue deserves further exploration. Better understanding of the direction of this relation could 
have important clinical and research implications. Given the considerable attention irritability 
has been given in the pediatric bipolar literature, the fact that the level of irritability may be 
driven by level of impairment, is provocative. This result gives further credence to the theory 
that irritability is a nonspecific symptom, not a hallmark feature of pediatric mania, as some have 
suggested (Biederman, et al., 2000). 
 Depressive irritability, as might be expected, is worse in youth with BP II than youth with 
cyclothymia. Though other forms of bipolar may also experience major depression, this is the 
primary feature of BP II; the ability to differentiate BP II from the subthreshold forms of the 
disorder is a good indicator that irritability is a factor in bipolar depression. Within the bipolar 
context, irritability during depressive episodes is less often discussed than irritability during 
elevated periods; this may be an oversight as the results of the current study indicate that 
depressive irritability also offers discriminative ability. 
Comorbidity. 
Nineteen of the 52 youth with cyclothymia (37%) met criteria for an anxiety disorder. 
Though this supports the hypothesis that comorbid anxiety would be common among the youth 
with cyclothymia, high rates of panic disorder and separation anxiety were expected, but not 
found. The rate of separation anxiety among the youth with cyclothymia (6%, n=3) was lower 
than expected and quite a bit lower than previous studies have found (rates range from 13-57%) 
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(Wagner, 2006). Although there is not an obvious reason for the low rate of separation anxiety in 
this sample (among all bipolar subtypes the rate was 9%), it may be that the age of the 
participants played a role; research has indicated that the prevalence of separation anxiety 
decreases from childhood to adolescence (Masi, Mucci, & Millepiedi, 2001). The complete lack 
of panic disorder among the youth with bipolar disorder in this sample is also surprising. 
However, 23 of the youth with bipolar disorder, including nine of the youth with cyclothymia, 
report experiencing panic attacks. This is consistent with a previous study of 93 bipolar youth, in 
which no comorbid panic disorder was found, but 8% of participants had panic attacks (Tillman, 
et al., 2003).  
 In contrast to the rate of comorbid anxiety, the rate of comorbid ADHD among the youth 
with cyclothymia (83%) was, if anything, higher than anticipated. Previous studies have found 
rates closer to 60% among both youth with cyclothymia and the other bipolar subtypes 
(Birmaher, et al., 2006; Findling, et al., 2005), though rates as high as 97% have been reported 
for BP I (Biederman, et al., 2005). More interesting is the fact that the youth with cyclothymia 
had higher rates of ADHD than the other bipolar subtypes. This may provide some support to the 
theory that cyclothymia is associated with more varied family history of psychiatric disorder, 
beyond just mood disorder, and that those with cyclothymia are more likely to also suffer from 
other disorders. Additionally, such high rates of comorbid ADHD confirm one of the primary 
challenges in diagnosing cyclothymia – differentiation from ADHD or ADHD plus depression. 
This is an important issue, especially at the clinical level, introducing concern regarding 
appropriate treatment, whether with stimulants, mood stabilizers, or one of the other 
pharmaceutical treatments for PBD. Given the number of overlapping symptoms between 
pediatric bipolar disorder and ADHD, the most reliable way of differentiating between the two 
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disorders may be to establish whether the symptoms are chronic or episodic (Galanter & 
Leibenluft, 2008). However, this distinction can become blurred in the case of cyclothymia 
because its mood episodes are long and, particularly in children, may appear to be a chronic 
condition, if remittance has never been achieved.  
When an ADHD diagnosis precedes a diagnosis of cyclothymia, it raises questions 
regarding the possibility of a form of ADHD that is, in fact, a bipolar prodrome. This question 
has been raised elsewhere (Biederman, Russell, Soriano, Wozniak, & Faraone, 1998; Chang, et 
al., 2003; Sachs, Baldassano, Truman, & Guille, 2000; Singh, et al., 2006), and it is clear that, 
though symptoms may overlap, the two disorders are distinct. However, what is less clear – and 
deserving of additional exploration – is the question of whether or not there are different variants 
of ADHD, some that are associated with greater risk of bipolar disorder, or perhaps a certain 
subtype of bipolar disorder, and some that are not. Currently, evidence is somewhat mixed, but it 
seems that people with bipolar disorder are more likely to have ADHD, whereas having ADHD 
is less associated with increased risk of bipolar (Galanter & Leibenluft, 2008; E Youngstrom, 
Arnold, & Frazier, 2010). A similar pattern is found in family studies, wherein family members 
of bipolar probands tend to have elevated rates of ADHD, but family members of ADHD 
probands are not at increased risk for bipolar disorder (Galanter & Leibenluft, 2008). While it 
does appear that there is a familial link between ADHD and bipolar disorder (Chang, Steiner, & 
Ketter, 2000; Faraone, Glatt, & Tsuang, 2003; Wozniak, Biederman, Mundy, Mennin, & 
Faraone, 1995), more work needs to be done to better understand this relation. There is evidence 
to suggest that bipolar disorder and ADHD share a number of risk factors – genetic, biologic, and 
environmental. It may be that, in many cases, the perceived relation between these two disorders 
has more to do with similarities in the underlying disease mechanism, resulting in the application 
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of two labels for one disorder, rather than true comorbidity (E Youngstrom, et al., 2010). Better 
understanding of the shared and unique risk factors and phenomenology of ADHD and bipolar 
disorder is important; there are significant implications for treatment and for the refinement of 
the current classification system.  
 Age of onset.  
The mean age of mood symptom onset for youth with cyclothymic disorder was six 
years, five months. This is well below the hypothesized age of ten. Traditionally, an age of onset 
this young would have likely been taken as a sign that the child was suffering from a disorder 
other than bipolar – very likely ADHD, given the criteria of onset prior to age seven. However, 
research increasingly indicates that bipolar disorder very often does begin in childhood 
(Lewinsohn, et al., 2000; Perlis, et al., 2004). And, while the differences in age of onset between 
bipolar subtypes failed to reach significance, the age of onset for youth with cyclothymia was a 
full year younger than that for BP I and NOS and two and a half years younger than onset for BP 
II. Given the relatively small number of participants from which to make these comparisons, 
additional, prospective research is indicated to further explore this potential difference. An 
earlier age of onset associated with cyclothymia could further support the idea that cyclothymia 
has a more trait-like, temperamental foundation and chronic course (B. Geller, Tillman, 
Bolhofner, & Zimerman, 2008; McElroy, et al., 1997; Perlis, et al., 2004).  
 The hypothesis that youth with cyclothymia would tend to have a depressive episode 
before exhibiting hypomanic symptoms was supported, although they were not any more likely 
than the other bipolar subtypes to exhibit this pattern. Previous research has repeatedly found 
that depressive episodes tend to precede [hypo]manic episodes in bipolar youth (Birmaher, 
Axelson, Goldstein, et al., 2009; Strober, et al., 1995). Unfortunately, these data tend to be 
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retrospective, as is the case with the current study; therefore, the report of symptom onset may be 
confounded with the increased likelihood that people with cyclothymia will seek treatment 
during depressive episodes (Akiskal, et al., 1977; E Youngstrom, 2009). Only a prospective 
study of pre-symptomatic youth can fully address this question.  
 Sleep disturbance. 
As expected, youth with cyclothymia reported disrupted sleep. Though the mean score on 
the P-GBI sleep subscale was lower than the mean score found previously for bipolar youth 
(Meyers & Youngstrom, 2008), it was significantly higher than the sleep disturbance reported by 
those youth without bipolar disorder in this sample. There is evidence to support the theory that 
bipolar disorders are caused, in part, by abnormalities of an individual’s circadian rhythms that 
can “trigger” affective episodes (Grandin, Alloy, & Abramson, 2006). Both depressive and 
manic episodes are often preceded by disrupted sleep, and when disrupted sleep continues, mood 
symptoms tend to be worse (Totterdell & Kellett, 2008). The fact that the youth with 
cyclothymia in this study shared symptoms of sleep disruption with the other bipolar subtypes – 
but not with those unaffected by bipolar disorders – is important in that, based on the circadian 
rhythm theory, it suggests a shared biology among the bipolar disorders. Furthermore, it lends 
credence to the belief that cyclothymia is, in fact, an episodic bipolar disorder, not simply a 
temperament style. In a treatment study of cyclothymia, focused on improving mood with 
cognitive-behavioral techniques, one of the primary outcomes was an improvement in both sleep 
duration and regularity of sleep patterns, suggesting a bidirectional relation between internal and 
external mood triggers (Totterdell & Kellett, 2008). Good sleep hygiene is often incorporated in 
treatment for bipolar disorders (Kowatch, Fristad, et al., 2005; Otto, Reilly-Harrington, & Sachs, 
2003; Schwartz & Feeny, 2007), but this result indicates that sleep disruption may be both a 
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symptom and a cause of mood disorder. Further investigation of the relation between circadian 
rhythms and bipolar mood may provide important insights regarding both the biological and 
environmental etiology of mood disorders. 
 Family history. 
Youth with cyclothymia did not differ from other bipolar subtypes in their reported 
family history of psychiatric disorder (mood or other). Youth with cyclothymia did have greater 
family history of psychiatric disorder than the non-bipolar youth. Furthermore, they had greater 
family history of mood disorder than those youth with disruptive behavior disorders or ADHD, 
but were not distinguishable from those with depression or depression plus ADHD based on 
family history of mood disorder. These results offer further evidence that cyclothymia is on the 
mood disorder spectrum, and is associated with heritable risk. However, this particular set of 
analyses is underpowered; many participants did not report family history. Additionally, the 
measure used to collect family history data is simplistic. Although this is a benefit in terms of 
ease of administration, it introduces limitations regarding the level of detail and specificity of the 
information provided. While we believe that the yes/no questions asked offer an appropriate 
proxy for family history, there is certainly a trade-off using a simple questionnaire like the 
QFMQ rather than a more detailed, structured interview to collect the information (Maxwell, 
1992; Nurnberger, Blehar, Kaufmann, & York-Cooler, 1994). Including a comprehensive 
evaluation of family history of mental illness is indicated for future studies of bipolar youth. 
 Taken as a whole, the results of the analyses for the validation of cyclothymia as a 
distinct subtype of bipolar disorder were inconclusive. Although the results of the hypotheses 
regarding differences between the youth with cyclothymia and youth with non-bipolar disorders 
were largely supported, the differences between the youth with cyclothymia and the other forms 
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of bipolar disorder – particularly BP NOS – were less consistent. However, this should not be 
taken as evidence that cyclothymia and BP NOS are indistinguishable or that cyclothymia is an 
unnecessary subtype. In fact, considering that the NOS diagnosis is meant to be assigned only to 
those who do not meet one of the other bipolar diagnoses, the overlap between cyclothymia and 
BP NOS in the present study suggests that some youth diagnosed with BP NOS belong within 
the cyclothymic subtype. Delineation of these subtypes is possible and important, particularly in 
research settings, where investigators are aiming to better understand and describe PBD.  
Conclusion. 
The present study explored both similarities and differences across the bipolar spectrum, 
the results indicate that cyclothymia is, in fact, on the bipolar spectrum (and would not be better 
cast as a temperament or personality disorder), but retains characteristics that distinguish it from 
the other subtypes. See Table 4. Were large differences found between subtypes on the 
characteristics explored, it might call into question whether or not the subtypes really belong in 
the same category. Distinguishing cyclothymia from BP NOS is, as hypothesized, challenging 
and perhaps not possible based on levels of irritability, comorbid diagnoses, or family history, 
alone. That is not to say that cyclothymia is distinguishable only by DSM criteria, which are 
admittedly flawed; many of the results seem to hint at differences that may have failed to reach 
significance simply because the sample was not large enough. Based on the findings in this 
study, further investigation of comorbid ADHD, family history and age of onset, in particular, is 
indicated. 
Limitations and future directions. 
The current study was proposed and executed as an exploration of the diagnosis of 
cyclothymic disorder in young people. Given the lack of previous research on this population, 
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this study contributed important information about the phenomenology, etiology and comorbid 
conditions associated with this disorder. Still, there are limitations worth noting. This study used 
a five-phase validation framework first proposed by Robins and Guze (1970), however data only 
exist to address three of the five categories of research. The remaining categories – Laboratory 
Studies and Follow-up Studies – could provide the best opportunity to learn about the origin and 
course of this chronic, debilitating disorder. New research investigating the biologic and genetic 
underpinnings of cyclothymic disorder could provide valuable insight into the disorder’s 
etiology, mechanics, and relation to other affective disorders. Because it is theorized that 
cyclothymia may result from a varied genetic foundation, resulting in more pervasive, 
undifferentiated impairment, the results of genetic and biologic studies are of particular interest. 
Greater understanding of the systems implicated in the origin and maintenance of cyclothymia 
could provide valuable clues into the development of effective treatments.  
The present study is unable to comment on characteristics of the course of cyclothymia, 
including episode pattern / duration and prognosis. Given that its chronic nature is one if the 
primary features of the disorder, this is a significant limitation. Unfortunately, cyclothymia has 
not been differentiated in any of the pediatric longitudinal studies reported to-date – even though 
the outcome for cyclothymic youth should be of great interest. Specifically, given that 
cyclothymia may be the most prevalent form of bipolar in adults – and that BP NOS is (by 
clinical diagnosis) more prevalent in children than adults, following the course of these two 
subthreshold forms of bipolar disorder may help to elucidate differences. Most importantly, what 
is the course of chronic, early-onset bipolar spectrum disorder? Who among the subthreshold 
cases goes on to develop BP I or II, whose symptoms remit? Data from a large, longitudinal 
study suggests that subsyndromal cases of pediatric bipolar disorder are likely to convert to BP I 
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or II (Birmaher, Axelson, Goldstein, et al., 2009; Birmaher, et al., 2006). However, this study 
does not distinguish between BP NOS and cyclothymic disorder, so it is impossible to draw 
conclusions about why 38% of cases progressed over the four-year follow-up and the rest did 
not. Additionally, there is evidence to suggest that some forms of pediatric bipolar disorder may 
resolve in young adulthood, without future episodes (Cicero, Epler, & Sher, 2009). Without 
prospective tracking of the specific characteristics of subthreshold bipolar subtypes, along with 
risk and protective factors, the gains possible from the field of bipolar research are limited – 
subthreshold subtypes likely represent the greatest opportunity for preventative measures 
(Miklowitz & Chang, 2008). 
In conclusion, the results of this study suggest that cyclothymia is firmly situated on the 
mood disorder spectrum. It shares characteristics with both other bipolar disorders and 
depression. In fact, the similarities found between people with cyclothymic disorder and those 
with depression plus ADHD (irritability, high comorbidity, sleep disturbance) may suggest that 
cyclothymia is an intermediate disorder on the spectrum between BP I and major depression. The 
discussion regarding whether or not depression and bipolar disorder are on the same spectrum is 
ongoing, but it seems that further investigation of cyclothymia may offer some answers, not only 
about the mood spectrum, but about its interactions with temperament, circadian rhythms and 
other disorders. 
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 Table 1. Mean POMP irritability scores from the P-GBI by diagnosis 
*Significantly different (p<.05) from cyclothymia based on Tukey’s HSD posthoc test 
 
 
 
 
Table 2. Comorbid diagnoses  
 N Mean number 
comorbid Dx 
% with comorbid 
anxiety  
% with comorbid 
ADHD § 
DBD 31 2.7(1.0)* 13 0 
ADHD 346 3.6(1.4)* 20 100 
Depression 126 3.6(1.8)* 38 0 
Depression + ADHD 127 4.7(1.6) 28 100 
Cyclothymia 52 4.9(1.6) 37 83 
BP NOS 52 4.2(1.6) 28 57 
BP II 18 4.2(2.2) 50 50 
BP I 31 4.0(1.6) 35 61 
*Significantly different (p<.05) from cyclothymia based on Tukey’s HSD posthoc test 
§the non-affective disorders were parsed based on ADHD status, within these categories either all or none of the participants have 
comorbid ADHD 
 
 
 
 
 
N Depressive 
Irritability 
Elevated 
Irritability 
Total Irritability Difference btwn 
Dep & Elevated 
DBD 31 12.1(16.7)* 9.7(15.1)* 11.5(15.9)* 2.4(10.2) 
ADHD 346 23.4(22.0)* 23.9(22.7)* 24.3(21.4)* .5(16.9) 
Depression 126 38.3(23.4) 20.5 (20.6)* 32.8(21.0) 17.8(19.6) 
Depression + ADHD 127 38.4(22.4) 29.0(23.6) 36.1(21.7) 9.4(18.4) 
Cyclothymia 52 42.8(19.1) 33.0(20.9) 40.5(17.9) 9.8(19.6) 
BP NOS 52 41.9(21.7) 35.7(24.9) 40.9(21.2) 6.2(20.8) 
BP II 18 60.7(16.6)* 37.0(20.1) 53.7(17.9)* 23.7(14.2) 
BP I 31 52.6(26.0) 47.9(25.7)* 52.5(24.9) 4.8(19.6) 
56 
 
Table 3. Percent with family risk factors for psychiatric disorder by diagnosis 
 
 N Family history of 
psychiatric disorder % 
Family history of 
mood disorder % 
Family history of 
Bipolar % 
DBD 11 85 62 23 
ADHD 88 72 55 30 
Depression 47 81 68 40 
Dep + ADHD 45 82 71 49 
Cyclothymia 15 100 93 60 
BP NOS 19 84 79 42 
BP II 6 83 50 33 
BP I 3 33 33 33 
 
 
 
Table 4. Results for original hypotheses on delimitation from other bipolar subtypes. Compared 
to youth with cyclothymic disorder, those with other BP subtypes differed on the following: 
 
Symptom Bipolar I Bipolar II Bipolar NOS 
Mania More severe Equivalent Often more severe 
Depression More severe More Severe Equivalent 
Total episode duration Shorter Shorter Equivalent 
Irritability Less chronic Less severe Less chronic 
Elevated both high & low* More severe high & low* Equivalent both high & low 
Age of Onset Later Later Equivalent 
Later, not sig @ p<.05 Later, not sig @ p<.05 Later, not sig @ p<.05 
Index episode Less likely depressed Less likely depressed Less likely depressed 
All BP depressed first All BP depressed first All BP depressed first 
Sleep disturbance More severe Equivalent More severe 
Equivalent More severe* Equivalent 
Family History Less mental illness Less mental illness Less mental illness 
Less, not sig @ p<.05 Less, not sig @ p<.05 Less, not sig @ p<.05 
 
 
*Significant result 
 
Original hypothesis 
Study result 
Not tested 
57 
 
Figure 1. Difference in irritability between depressive and elevated periods 
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Figure 2. Survival analysis of age of mood symptom onset by bipolar subtype 
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